BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Armstrong H, Bording-Jorgensen M, Dijk S, Wine E. The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It. Cancers (Basel) 2018;10:E83. [PMID: 29558443 DOI: 10.3390/cancers10030083] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Devoy C, Flores Bueso Y, Tangney M. Understanding and harnessing triple-negative breast cancer-related microbiota in oncology. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1020121] [Reference Citation Analysis]
2 Hou Y, Zhao W, Yang Z, Zhang B. Serum amyloid A (SAA) and Interleukin-6 (IL-6) as the potential biomarkers for gastric cancer. Medicine (Baltimore) 2022;101:e31514. [PMID: 36316846 DOI: 10.1097/MD.0000000000031514] [Reference Citation Analysis]
3 Shrode R, Knobbe J, Cady N, Yadav M, Hoang J, Cherwin C, Curry M, Garje R, Vikas P, Sugg S, Phadke S, Filardo E, Mangalam A. Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria.. [DOI: 10.21203/rs.3.rs-2180299/v1] [Reference Citation Analysis]
4 Zaidi AH, Pratama MY, Omstead AN, Gorbonova A, Mansoor R, Melton-kreft R, Jobe BA, Wagner PL, Kelly RJ, Goel A. A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma. Br J Cancer. [DOI: 10.1038/s41416-022-01974-5] [Reference Citation Analysis]
5 Boulaka A, Mantellou P, Stanc G, Souka E, Valavanis C, Saxami G, Mitsou E, Koutrotsios G, Zervakis GI, Kyriacou A, Pletsa V, Georgiadis P. Genoprotective activity of the Pleurotus eryngii mushrooms following their in vitro and in vivo fermentation by fecal microbiota. Front Nutr 2022;9:988517. [DOI: 10.3389/fnut.2022.988517] [Reference Citation Analysis]
6 Hinshaw DC, Swain CA, Chen D, Hanna A, Molina PA, Maynard CL, Lee G, Mcfarland BC, Samant RS, Shevde LA. Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8+ T cells in a mouse model of mammary carcinoma. Lab Invest 2022. [DOI: 10.1038/s41374-022-00828-1] [Reference Citation Analysis]
7 Niemiec MJ, Kapitan M, Himmel M, Döll K, Krüger T, Köllner TG, Auge I, Kage F, Alteri CJ, Mobley HL, Monsen T, Linde S, Nietzsche S, Kniemeyer O, Brakhage AA, Jacobsen ID. Augmented Enterocyte Damage During Candida albicans and Proteus mirabilis Coinfection. Front Cell Infect Microbiol 2022;12:866416. [DOI: 10.3389/fcimb.2022.866416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gheorghe DN, Camen A, Popescu DM, Sincar C, Pitru A, Ionele CM, Nicolae FM, Danilescu CM, Roman A, Florescu C. Periodontitis, Metabolic and Gastrointestinal Tract Diseases: Current Perspectives on Possible Pathogenic Connections. JPM 2022;12:341. [DOI: 10.3390/jpm12030341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Merali N, Chouari T, Kayani K, Rayner CJ, Jiménez JI, Krell J, Giovannetti E, Bagwan I, Relph K, Rockall TA, Dhillon T, Pandha H, Annels NE, Frampton AE. A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma. Cancers 2022;14:1020. [DOI: 10.3390/cancers14041020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Riedel S, Pheiffer C, Johnson R, Louw J, Muller CJF. Intestinal Barrier Function and Immune Homeostasis Are Missing Links in Obesity and Type 2 Diabetes Development. Front Endocrinol 2022;12:833544. [DOI: 10.3389/fendo.2021.833544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Archna, Chawla PA, Teli G, Pathania S, Singh S, Srivastava V. Exploration of Antioxidant, Anti-inflammatory and Anticancer Potential of Substituted 4-Thiazolidinone Derivatives: Synthesis, Biological Evaluation and Docking Studies. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2021.2019796] [Reference Citation Analysis]
12 蘧 曼. Research Progress of Microbiome in Breast Cancer. ACM 2022;12:1555-1563. [DOI: 10.12677/acm.2022.123224] [Reference Citation Analysis]
13 Rais A, Chand P, Malik M, Prasad T. Human microbiota: role in cancer progression and therapy. Microbial Crosstalk with Immune System 2022. [DOI: 10.1016/b978-0-323-96128-8.00006-7] [Reference Citation Analysis]
14 Dzikowiec M, Pastuszak-lewandoska D. The uninvited guests of our microbiome: Helicobacter pylori and Epstein-Barr virus and their role in gastric cancerogenesis. Postępy Higieny i Medycyny Doświadczalnej 2021;75:611-9. [DOI: 10.2478/ahem-2021-0008] [Reference Citation Analysis]
15 Kossai M, Radosevic-Robin N, Penault-Llorca F. Refining patient selection for breast cancer immunotherapy: beyond PD-L1. ESMO Open 2021;6:100257. [PMID: 34487970 DOI: 10.1016/j.esmoop.2021.100257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Xu T, Xie M, Jing X, Cui J, Wu X, Shu Y. Crosstalk between Environmental Inflammatory Stimuli and Non-Coding RNA in Cancer Occurrence and Development. Cancers (Basel) 2021;13:4436. [PMID: 34503246 DOI: 10.3390/cancers13174436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 El-Sayed A, Aleya L, Kamel M. Microbiota and epigenetics: promising therapeutic approaches? Environ Sci Pollut Res Int 2021. [PMID: 34319520 DOI: 10.1007/s11356-021-15623-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
18 Kabir M, Ashfaq M, Saeed S, Arshad M, Asif H. Assessment of dietary intake among patients with peptic ulcer. DF 2021. [DOI: 10.54393/df.v3i01.29] [Reference Citation Analysis]
19 Haß U, Schütte O, Franz K, Norman K. Dietary Inflammatory Index (DII) – Nützlicher Wegweiser in der praktischen Beratung oder rein theoretisches Modell in der Ernährungsforschung? Aktuelle Ernährungsmedizin 2021;46:174-185. [DOI: 10.1055/a-1299-1190] [Reference Citation Analysis]
20 Jiang Z, Li L, Chen J, Wei G, Ji Y, Chen X, Liu J, Huo J. Human gut-microbiome interplay: Analysis of clinical studies for the emerging roles of diagnostic microbiology in inflammation, oncogenesis and cancer management. Infect Genet Evol 2021;93:104946. [PMID: 34052417 DOI: 10.1016/j.meegid.2021.104946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Bonde A, Daly S, Kirsten J, Kondapaneni S, Mellnick V, Menias CO, Katabathina VS. Human Gut Microbiota-associated Gastrointestinal Malignancies: A Comprehensive Review. Radiographics 2021;41:1103-22. [PMID: 33989072 DOI: 10.1148/rg.2021200168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Zhu R, Lang T, Yan W, Zhu X, Huang X, Yin Q, Li Y. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Adv Sci (Weinh) 2021;8:2003542. [PMID: 34026439 DOI: 10.1002/advs.202003542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
23 Park JM, Lee WH, Seo H, Oh JY, Lee DY, Kim SJ, Hahm KB. Microbiota changes with fermented kimchi contributed to either the amelioration or rejuvenation of Helicobacter pylori-associated chronic atrophic gastritis. J Clin Biochem Nutr 2021;69:98-110. [PMID: 34376919 DOI: 10.3164/jcbn.20-123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ivanenko N. BIOFILM AND TUMOR: INTERPRETATION OF INTERACTION AND TREATMENT STRATEGIES. Review. Med Sci of Ukr 2021;17:104-20. [DOI: 10.32345/2664-4738.1.2021.13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Armstrong H, Bording-Jorgensen M, Wine E. The Multifaceted Roles of Diet, Microbes, and Metabolites in Cancer. Cancers (Basel) 2021;13:767. [PMID: 33673140 DOI: 10.3390/cancers13040767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wei X, Mei C, Li X, Xie Y. The Unique Microbiome and Immunity in Pancreatic Cancer. Pancreas 2021;50:119-29. [DOI: 10.1097/mpa.0000000000001744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
27 Armstrong H, Mander I, Zhang Z, Armstrong D, Wine E. Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD. Front Pediatr 2020;8:620189. [PMID: 33520902 DOI: 10.3389/fped.2020.620189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
28 George ES, Sood S, Broughton A, Cogan G, Hickey M, Chan WS, Sudan S, Nicoll AJ. The Association between Diet and Hepatocellular Carcinoma: A Systematic Review. Nutrients 2021;13:E172. [PMID: 33430001 DOI: 10.3390/nu13010172] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
29 Li W, Xu J, Zhang R, Li Y, Wang J, Zhang X, Lin L. Is periodontal disease a risk indicator for colorectal cancer? A systematic review and meta-analysis. J Clin Periodontol 2021;48:336-47. [PMID: 33179280 DOI: 10.1111/jcpe.13402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
30 Zhang X, Daniel CR. Diet, Microbiome, Inflammation, and Cancer. Physiology in Health and Disease 2021. [DOI: 10.1007/978-3-030-67951-4_11] [Reference Citation Analysis]
31 Al Bander Z, Nitert MD, Mousa A, Naderpoor N. The gut microbiota and inflammation: An overview. Int J Environ Res Public Health. 2020;17. [PMID: 33086688 DOI: 10.3390/ijerph17207618] [Cited by in Crossref: 99] [Cited by in F6Publishing: 112] [Article Influence: 49.5] [Reference Citation Analysis]
32 Daouk R, Bahmad HF, Saleh E, Monzer A, Ballout F, Kadara H, Abou-Kheir W. Genome-wide gene expression analysis of a murine model of prostate cancer progression: Deciphering the roles of IL-6 and p38 MAPK as potential therapeutic targets. PLoS One 2020;15:e0237442. [PMID: 32790767 DOI: 10.1371/journal.pone.0237442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Chadha J, Nandi D, Atri Y, Nag A. Significance of human microbiome in breast cancer: Tale of an invisible and an invincible. Semin Cancer Biol 2021;70:112-27. [PMID: 32717337 DOI: 10.1016/j.semcancer.2020.07.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
34 Li Z, Hou Y, Zhao M, Li T, Liu Y, Chang J, Ren L. Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression. J Ovarian Res 2020;13:67. [PMID: 32517794 DOI: 10.1186/s13048-020-00669-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
35 Raji Lahiji M, Najafi S, Janani L, Yazdani B, Razmpoosh E, Zarrati M. The effect of synbiotic on glycemic profile and sex hormones in overweight and obese breast cancer survivors following a weight-loss diet: A randomized, triple-blind, controlled trial. Clin Nutr 2021;40:394-403. [PMID: 32698957 DOI: 10.1016/j.clnu.2020.05.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
36 Ansari MH, Ebrahimi M, Fattahi MR, Gardner MG, Safarpour AR, Faghihi MA, Lankarani KB. Viral metagenomic analysis of fecal samples reveals an enteric virome signature in irritable bowel syndrome. BMC Microbiol 2020;20:123. [PMID: 32429898 DOI: 10.1186/s12866-020-01817-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
37 Cheung MK, Yue GGL, Chiu PWY, Lau CBS. A Review of the Effects of Natural Compounds, Medicinal Plants, and Mushrooms on the Gut Microbiota in Colitis and Cancer. Front Pharmacol 2020;11:744. [PMID: 32499711 DOI: 10.3389/fphar.2020.00744] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
38 Eslami-S Z, Majidzadeh-A K, Halvaei S, Babapirali F, Esmaeili R. Microbiome and Breast Cancer: New Role for an Ancient Population. Front Oncol 2020;10:120. [PMID: 32117767 DOI: 10.3389/fonc.2020.00120] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 28.0] [Reference Citation Analysis]
39 Martinson HA, Mallari D, Richter C, Wu TT, Tiesinga J, Alberts SR, Olnes MJ. Molecular Classification of Gastric Cancer among Alaska Native People. Cancers (Basel) 2020;12:E198. [PMID: 31941061 DOI: 10.3390/cancers12010198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
40 Okeleye BI, Okudoh VI, Ntwampe SK. The role of microbial pathogens in cancer development: a potential guide to anticancer drugs. Microorganisms for Sustainable Environment and Health 2020. [DOI: 10.1016/b978-0-12-819001-2.00023-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Wang Y, Yang G, You L, Yang J, Feng M, Qiu J, Zhao F, Liu Y, Cao Z, Zheng L, Zhang T, Zhao Y. Role of the microbiome in occurrence, development and treatment of pancreatic cancer. Mol Cancer. 2019;18:173. [PMID: 31785619 DOI: 10.1186/s12943-019-1103-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
42 Plaza-Díaz J, Álvarez-Mercado AI, Ruiz-Marín CM, Reina-Pérez I, Pérez-Alonso AJ, Sánchez-Andujar MB, Torné P, Gallart-Aragón T, Sánchez-Barrón MT, Reyes Lartategui S, García F, Chueca N, Moreno-Delgado A, Torres-Martínez K, Sáez-Lara MJ, Robles-Sánchez C, Fernández MF, Fontana L. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study. BMC Cancer 2019;19:495. [PMID: 31126257 DOI: 10.1186/s12885-019-5660-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]
43 Banks KC, Ericsson AC, Reinero CR, Giuliano EA. Veterinary ocular microbiome: Lessons learned beyond the culture. Vet Ophthalmol 2019;22:716-25. [PMID: 31070001 DOI: 10.1111/vop.12676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
44 Rizzato C, Torres J, Kasamatsu E, Camorlinga-Ponce M, Bravo MM, Canzian F, Kato I. Potential Role of Biofilm Formation in the Development of Digestive Tract Cancer With Special Reference to Helicobacter pylori Infection. Front Microbiol 2019;10:846. [PMID: 31110496 DOI: 10.3389/fmicb.2019.00846] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 12.7] [Reference Citation Analysis]
45 Zeng H, Umar S, Rust B, Lazarova D, Bordonaro M. Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer. Int J Mol Sci 2019;20:E1214. [PMID: 30862015 DOI: 10.3390/ijms20051214] [Cited by in Crossref: 150] [Cited by in F6Publishing: 156] [Article Influence: 50.0] [Reference Citation Analysis]
46 Pandey SK, Yadav S, Goel Y, Temre MK, Singh VK, Singh SM. Molecular docking of anti-inflammatory drug diclofenac with metabolic targets: Potential applications in cancer therapeutics. Journal of Theoretical Biology 2019;465:117-25. [DOI: 10.1016/j.jtbi.2019.01.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
47 Cianci R, Franza L, Schinzari G, Rossi E, Ianiro G, Tortora G, Gasbarrini A, Gambassi G, Cammarota G. The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer. Int J Mol Sci 2019;20:E501. [PMID: 30682772 DOI: 10.3390/ijms20030501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
48 Armstrong H, Alipour M, Valcheva R, Bording-Jorgensen M, Jovel J, Zaidi D, Shah P, Lou Y, Ebeling C, Mason AL, Lafleur D, Jerasi J, Wong GK, Madsen K, Carroll MW, Huynh HQ, Dieleman LA, Wine E. Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases. Microbiome 2019;7:1. [PMID: 30606251 DOI: 10.1186/s40168-018-0604-3] [Cited by in Crossref: 97] [Cited by in F6Publishing: 103] [Article Influence: 32.3] [Reference Citation Analysis]
49 Driscoll K, Deshpande A, Chapp A, Li K, Datta R, Ramakrishna W. Anti-inflammatory and immune-modulating effects of rice callus suspension culture (RCSC) and bioactive fractions in an in vitro inflammatory bowel disease model. Phytomedicine 2019;57:364-76. [PMID: 30831485 DOI: 10.1016/j.phymed.2018.12.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
50 Louise Møller Nordestgaard R, Roed Spiegelhauer M, Havnhøj Frandsen T, Gren C, Tving Stauning A, Percival Andersen L. Clinical Manifestations of the Epsilonproteobacteria (Helicobacter pylori). Helicobacter pylori [Working Title] 2018. [DOI: 10.5772/intechopen.80331] [Reference Citation Analysis]
51 Fernández MF, Reina-Pérez I, Astorga JM, Rodríguez-Carrillo A, Plaza-Díaz J, Fontana L. Breast Cancer and Its Relationship with the Microbiota. Int J Environ Res Public Health 2018;15:E1747. [PMID: 30110974 DOI: 10.3390/ijerph15081747] [Cited by in Crossref: 137] [Cited by in F6Publishing: 146] [Article Influence: 34.3] [Reference Citation Analysis]
52 Hua H, Zhang H, Kong Q, Wang J, Jiang Y. Complex roles of the old drug aspirin in cancer chemoprevention and therapy. Med Res Rev 2019;39:114-45. [PMID: 29855050 DOI: 10.1002/med.21514] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 15.0] [Reference Citation Analysis]